APA (7th ed.) Citation

Chevalier, T., Daste, A., Saada‐Bouzid, E., Loundou, A., Peyraud, F., Lambert, T., . . . Salas, S. (2021). Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME. Cancer Medicine, 1. https://doi.org/10.1002/cam4.3953

Chicago Style (17th ed.) Citation

Chevalier, Thomas, et al. "Cetuximab Combined with Paclitaxel or Paclitaxel Alone for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Progressing After EXTREME." Cancer Medicine 2021: 1. https://doi.org/10.1002/cam4.3953.

MLA (9th ed.) Citation

Chevalier, Thomas, et al. "Cetuximab Combined with Paclitaxel or Paclitaxel Alone for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Progressing After EXTREME." Cancer Medicine, 2021, p. 1, https://doi.org/10.1002/cam4.3953.